A detailed history of Assenagon Asset Management S.A. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 4,483 shares of AXSM stock, worth $390,065. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,483
Previous 33,969 86.8%
Holding current value
$390,065
Previous $2.73 Million 85.3%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$78.93 - $95.84 $2.33 Million - $2.83 Million
-29,486 Reduced 86.8%
4,483 $402,000
Q2 2024

Jul 18, 2024

BUY
$65.72 - $80.5 $2.23 Million - $2.73 Million
33,969 New
33,969 $2.73 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.73B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.